BDog, impressive piece of literature from memory, thank you for taking the time and effort. It all sounds about right from what I have read in the last few months (newbie).

At the risk of getting the Irish up in anyone and since all the positives seem to add up then why the delays. I do appreciate it needs to be done right the first time, I applaud that. Did they just get sidetracked chasing new massive markets/indications because they had time while waiting for Amarex? HIV is big with recurring revs but I dare say it is dwarfed by the cancer potential. I sure would like to close the door with a solid argument on my only remaining question.